Yes, gus66. And on October 22, Chairman Brian Leedman said this: “The newly in-licensed cannabis strains for treating neurological disorders represent tremendous commercial opportunities that match perfectly with the use of our Mente platform for monitoring patients in our forthcoming clinical studies”.
3c M/C $18m going to 20c M/C $120m in 150 days, page-12
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
-0.002(3.92%) |
Mkt cap ! $50.69M | |||
| Open | High | Low | Value | Volume |
| 5.1¢ | 5.1¢ | 4.9¢ | $52.10K | 1.049M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 325144 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 197439 | 3 |
View Market Depth
| Last trade - 15.58pm 14/10/2024 (20 minute delay) ? |
| NTI (ASX) Chart |